Ekso Bionics (EKSO) Reports Q1 Loss, Misses Revenue Estimates

  • Ekso Bionics (EKSO) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.20 per share a year ago.